How Emerging AI Capabilities Are Reshaping Life Sciences
Artificial Intelligence (AI) is rapidly redefining how the Life Science industry innovates, operates, and delivers value. From accelerating drug discovery to optimizing clinical trials and enabling data-driven commercialization, AI has become a cornerstone of modern Life Science transformation. As emerging AI capabilities mature, organizations are moving beyond experimentation toward enterprise-wide adoption that delivers measurable outcomes. This blog explores how AI […]
Agentic AI in Life Sciences: Driving the Era of Autonomous Decisions
In the rapidly evolving landscape of life sciences, Agentic AI is emerging as a game-changer, enabling systems to operate with unprecedented autonomy. Unlike traditional AI, which primarily generates responses or predictions, Agentic AI takes proactive steps, making decisions and executing tasks independently to achieve specific goals. This shift toward autonomous decision-making is reshaping how life […]
How Generative AI is Transforming Life Sciences
The future of R&D in Life Science hinges on using intelligent technologies to dramatically improve cycle times, success rates, and efficiency. A McKinsey study finds Generative AI (GenAI) could generate $60 billion to $110 billion annually in economic value for pharmaceutical and medtech companies with its ability to ability to predict off-target effects, optimize drug […]
Accelerating Drug Research with AI in Clinical Trials
AI in clinical trials accelerates drug discovery by streamlining data analysis, predicting patient outcomes, and segregating cohort for trial.
Gleecus Visit to AWS re:Invent 2023, VigeoDash, and ValidationMaster Headquarters
Gleecus TechLabs Inc. recently attended the AWS re:Invent 2023 in Las Vegas and also caught up with prominent clients, VigeoDash and ValidationMaster